sulpiride has been researched along with Menopause in 50 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A number of studies have been conducted to determine the effectiveness of veralipride (Agreal) in the treatment of the psycho-functional manifestations of menopause." | 3.67 | [Agreal: clinical experience. Review of the literature]. ( Brient-Clabaux, J, 1985) |
| "The influence of endogenous opioid peptides on body thermoregulation has been studied in untreated postmenopausal women and in the same subjects after chronic administration of the antidopaminergic drug veralipride (200 mg/day for 20 days)." | 2.66 | Interaction between veralipride and the endogenous opioid system in the regulation of body temperature in postmenopausal women. ( Cagnacci, A; Fioretti, P; Melis, GB; Paoletti, AM; Soldani, R, 1988) |
| " Incidence of adverse events in a Mexican population and drug compliance according to correct use were evaluated." | 1.40 | Safety of veralipride for the treatment of vasomotor symptoms of menopause. ( Álvarez, IM; Arias, Mde J; Bonilla, MC; Campero, RA; Campos, ER; Escudero, RB; Flores, JB; González, CC; González, JH; Haro, SS; Marín, IH; Rodríguez, MA; Valencia, MH; Vargas, MA, 2014) |
| "The third chapter develops non-hormonal treatments of menopause, their specific mode of action and advantages, with a reference to veralipride." | 1.27 | [Cancer and menopause]. ( Olivier, JP, 1984) |
| "The author has studied the effects of the long-term administration (mean: 8 months) of veralipride in 12 menopausal women (7 naturally, 5 surgically)." | 1.27 | [Tolerance to veralipride administered for an extended time]. ( Milliez, J, 1984) |
| " Chronic administration of veralipride resulted in a significant (P less than 0." | 1.27 | Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride. ( Cagnacci, A; Fioretti, P; Gambacciani, M; Melis, GB; Moggi, L; Paoletti, AM, 1988) |
| "The effect of acute and chronic administration of sulpiride sulphate on serum prolactin levels in humans was studied." | 1.26 | Effect of sulpiride on serum prolactin levels in humans. ( Aparicio, NJ; Debeljuk, L; Guitelman, A; Mancini, AM; Vargas, CA, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (72.00) | 18.7374 |
| 1990's | 4 (8.00) | 18.2507 |
| 2000's | 4 (8.00) | 29.6817 |
| 2010's | 6 (12.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valencia, MH | 1 |
| Arias, Mde J | 1 |
| González, CC | 1 |
| Marín, IH | 1 |
| González, JH | 1 |
| Campos, ER | 1 |
| Rodríguez, MA | 1 |
| Álvarez, IM | 1 |
| Vargas, MA | 1 |
| Flores, JB | 1 |
| Haro, SS | 1 |
| Bonilla, MC | 1 |
| Escudero, RB | 1 |
| Campero, RA | 1 |
| Silvestre, FJ | 1 |
| Silvestre-Rangil, J | 1 |
| López-Jornet, P | 1 |
| Carretti, N | 1 |
| Florio, P | 1 |
| Reis, FM | 1 |
| Comai, S | 1 |
| Bertazzo, A | 1 |
| Petraglia, F | 1 |
| Carranza-Lira, S | 2 |
| Kepska, A | 1 |
| Hawro, T | 1 |
| Krupinska-Kun, M | 1 |
| Zalewska, A | 1 |
| Basavilvazo-Rodríguez, A | 1 |
| Bravo-Rodríguez, LM | 1 |
| Celis-González, C | 1 |
| Hernández Marín, I | 1 |
| Hernández-Valencia, M | 1 |
| López Navarro, ME | 1 |
| Alvarado Maldonado, Jde D | 1 |
| Armando Montaño, J | 1 |
| Moreno Avellán, AJ | 1 |
| Vázquez, G | 1 |
| Winterhoff, H | 1 |
| Spengler, B | 1 |
| Christoffel, V | 1 |
| Butterweck, V | 1 |
| Löhning, A | 1 |
| Fitzpatrick, LA | 1 |
| Marzo-Castillejo, M | 1 |
| Alonso-Coello, P | 1 |
| Buvat, J | 1 |
| Buvat-Herbaut, M | 1 |
| Linquette, M | 1 |
| Rivière, J | 1 |
| Vague, J | 1 |
| Quereux, C | 2 |
| Ezes, H | 1 |
| Deltour, G | 1 |
| Decaux, J | 1 |
| Dorangeon, P | 1 |
| Wahl, P | 2 |
| Sadrin, R | 1 |
| Evrard, G | 1 |
| Adnet, JJ | 1 |
| Wesel, S | 1 |
| L'Hermite, M | 2 |
| Delanian, L | 1 |
| Angeli, S | 1 |
| Fougère, P | 1 |
| Lefevre, J | 1 |
| Gicquel, A | 1 |
| Laffargue, F | 1 |
| Viala, JL | 2 |
| Durand, G | 1 |
| Olivier, JP | 1 |
| Piccione, E | 2 |
| Sesti, F | 1 |
| Manna, C | 1 |
| Milliez, J | 1 |
| Caputo, G | 1 |
| Gioffrè, MA | 1 |
| Micali, B | 1 |
| Lucania, L | 1 |
| Venuti, A | 1 |
| Franchignoni, FP | 1 |
| Tesio, L | 1 |
| Iruela, LM | 1 |
| Caballero, L | 1 |
| Ibánez-Rojo, V | 1 |
| Palanca, I | 1 |
| Marta-Moreno, E | 1 |
| Gracia-Naya, M | 1 |
| Marzo-Sola, ME | 1 |
| Teive, HA | 1 |
| Sa, DS | 1 |
| Vermeulen, A | 1 |
| Suy, E | 1 |
| Rubens, R | 1 |
| Dor, P | 1 |
| Muquardt, C | 1 |
| Borkowski, A | 1 |
| Trévoux, R | 1 |
| Netter, A | 1 |
| Gayral, MN | 1 |
| Millet, D | 1 |
| Mancini, AM | 2 |
| Guitelman, A | 2 |
| Debeljuk, L | 2 |
| Vargas, CA | 2 |
| Aparicio, NJ | 1 |
| Gabellini, AS | 1 |
| Pezzoli, A | 1 |
| De Massis, P | 1 |
| Sacquegna, T | 1 |
| Nakano, R | 2 |
| Nishi, T | 2 |
| Yagi, S | 1 |
| Fioretti, P | 4 |
| Cagnacci, A | 4 |
| Paoletti, AM | 4 |
| Gambacciani, M | 3 |
| Soldani, R | 2 |
| Mauro, GA | 1 |
| Spinetti, A | 1 |
| Melis, GB | 4 |
| Moggi, L | 1 |
| Boulot, P | 1 |
| Mais, V | 1 |
| Verbeke, K | 1 |
| Dhont, M | 1 |
| Vandekerckhove, D | 1 |
| De Cecco, L | 1 |
| Venturini, PL | 1 |
| Alibrandi, MP | 1 |
| Grondona, AL | 1 |
| Morano, S | 1 |
| Penna, L | 1 |
| Campanella, G | 1 |
| Ragni, N | 1 |
| Pasetto, N | 1 |
| Baschieri, L | 1 |
| Brient-Clabaux, J | 2 |
| Marais, C | 1 |
| Dargent, D | 1 |
| Dumont, M | 1 |
| Malinas, Y | 1 |
| Rerolle, G | 1 |
| Ruf, H | 1 |
| Lanza, M | 1 |
5 reviews available for sulpiride and Menopause
| Article | Year |
|---|---|
Burning mouth syndrome: a review and update.
Topics: Adult; Age Distribution; Aged; Algorithms; Amisulpride; Antidepressive Agents; Burning Mouth Syndrom | 2015 |
Actual status of veralipride use.
Topics: Antipsychotic Agents; Female; Hot Flashes; Humans; Menopause; Sulpiride | 2010 |
Alternatives to estrogen.
Topics: Acetates; Acupuncture Therapy; Adrenergic alpha-Agonists; Amines; Antidepressive Agents, Second-Gene | 2003 |
[New data on the physiology and treatment of vasomotor menopausal flushing].
Topics: Animals; Climacteric; Clonidine; Estrogens; Female; Haplorhini; Humans; Hypothalamic Hormones; Hypot | 1983 |
[Possibilities and limits of non-hormonal therapy of the menopausal syndrome].
Topics: Bromocriptine; Climacteric; Clonidine; Dopamine; Female; Gonadotropin-Releasing Hormone; Humans; Men | 1984 |
9 trials available for sulpiride and Menopause
| Article | Year |
|---|---|
Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes.
Topics: Analysis of Variance; Chromatography, High Pressure Liquid; Dopamine Antagonists; Double-Blind Metho | 2010 |
[Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
Topics: Adult; Climacteric; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Menopause; Middle | 1980 |
[A new therapeutic approach to menopausal sudden flushes and psychofunctional disorders (author's transl)].
Topics: Adult; Castration; Climacteric; Clinical Trials as Topic; Female; Humans; Menopause; Middle Aged; Pr | 1980 |
[Clinical study of veralipride in menopausal sudden flushes (author's transl)].
Topics: Adult; Blood Cell Count; Climacteric; Clinical Trials as Topic; Creatinine; Double-Blind Method; Fem | 1980 |
[Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
Topics: Adult; Climacteric; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Menopause; Middle | 1980 |
[A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
Topics: Adult; Aged; Climacteric; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Female; Hum | 1988 |
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
Topics: Climacteric; Clinical Trials as Topic; Dopamine Antagonists; Double-Blind Method; Estradiol; Female; | 1988 |
Interaction between veralipride and the endogenous opioid system in the regulation of body temperature in postmenopausal women.
Topics: Body Temperature; Body Temperature Regulation; Endorphins; Female; Humans; Menopause; Middle Aged; N | 1988 |
[Non-hormonal treatment of hot flashes and other menopausal disorders].
Topics: Clinical Trials as Topic; Drug Tolerance; Female; Headache; Humans; Lactation Disorders; Menopause; | 1973 |
36 other studies available for sulpiride and Menopause
| Article | Year |
|---|---|
Safety of veralipride for the treatment of vasomotor symptoms of menopause.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Menopause; Middle Aged; Patient Satis | 2014 |
Somatic-type delusional disorder: a case report and comments.
Topics: Antipsychotic Agents; Delusions; Female; Humans; Menopause; Middle Aged; Somatoform Disorders; Sulpi | 2011 |
[Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms].
Topics: Female; Humans; Menopause; Mexican Americans; Patient Selection; Sulpiride; Vasomotor System | 2012 |
Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity.
Topics: Animals; Behavior, Animal; Body Temperature; Cimicifuga; Depression; Dose-Response Relationship, Dru | 2003 |
[Clinical guide to the menopause and post-menopause].
Topics: Aged; Female; Fractures, Bone; Humans; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Postmen | 2005 |
[Vaginal smear cytology and hormonal tests before and after treatment with veralipride. Results in eleven cases (author's transl)].
Topics: Adult; Estrogens; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Menop | 1980 |
[Intractable menopausal disorders cured by veralipride (author's transl)].
Topics: Adult; Climacteric; Female; Humans; Hysterectomy; Hysteria; Menopause; Sulpiride | 1982 |
[A clinical trial of veralipride in menopausal complaints (author's transl)].
Topics: Adult; Female; Humans; Menopause; Middle Aged; Sulpiride | 1982 |
[Treatment of early menopause. A report of 2 cases].
Topics: Adult; Drug Therapy, Combination; Estradiol; Female; Humans; Menopause; Menopause, Premature; Norpro | 1983 |
[Veralipride and menopause].
Topics: Castration; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Age | 1983 |
[Cancer and menopause].
Topics: Estrogens; Female; Humans; Menopause; Neoplasms; Sulpiride | 1984 |
[Tolerance to veralipride administered for an extended time].
Topics: Drug Tolerance; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Prolactin; Psychophysiologic | 1984 |
[Effect of sulpiride on the secretion of prolactin and somatotropic hormone in premenopausal women affected by fibrocystic mastopathy].
Topics: Adult; Female; Fibrocystic Breast Disease; Growth Hormone; Humans; Menopause; Middle Aged; Pituitary | 1983 |
[Parkinson syndrome induced by veralipride].
Topics: Dopamine Antagonists; Female; Humans; Menopause; Middle Aged; Parkinson Disease, Secondary; Sulpirid | 1995 |
Panic-like symptoms after veralipride withdrawal.
Topics: Female; Humans; Menopause; Middle Aged; Norepinephrine; Panic Disorder; Psychophysiologic Disorders; | 1993 |
[Respiratory dyskinesia induced by veralipride].
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Menopause; Middle Aged; Respiration | 1997 |
Worsening of Parkinsonism after the use of veralipride for treatment of menopause: case report.
Topics: Dopamine Antagonists; Female; Humans; Menopause; Middle Aged; Parkinson Disease; Parkinson Disease, | 2001 |
Effect of prolactin on plasma DHEA (s) levels.
Topics: Adult; Aged; Antidepressive Agents; Dehydroepiandrosterone; Dementia; Depression; Estrogens; Female; | 1977 |
Influence of corticotrophin and prolactin on the steroid sex hormones and their precursors in postmenopausal women.
Topics: Adrenocorticotropic Hormone; Aged; Female; Gonadal Steroid Hormones; Humans; Menopause; Middle Aged; | 1978 |
[A previously unpublished indication for sulpiride: functional uterine hemorrhages].
Topics: Adult; Drug Evaluation; Female; Humans; Hypothalamus; Menopause; Menorrhagia; Metrorrhagia; Middle A | 1977 |
[The gonadotropic hypothalamus. Its development from the embryonic period to the menopause].
Topics: Adolescent; Adult; Dopamine; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing | 1976 |
Effect of administration of sulpiride on serum follicle-stimulating hormone and luteinizing hormone levels in a group of postmenopausal women.
Topics: Adult; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Su | 1975 |
Effect of sulpiride on serum prolactin levels in humans.
Topics: Adolescent; Adult; Female; Humans; Male; Menopause; Menstruation; Middle Aged; Prolactin; Sex Factor | 1976 |
Veralipride-induced tardive dystonia in a patient with bipolar psychosis.
Topics: Dystonia; Female; Humans; Menopause; Middle Aged; Psychotic Disorders; Sulpiride | 1992 |
Progesterone feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
Topics: Aged; Aged, 80 and over; Ethinyl Estradiol; Feedback; Female; Follicle Stimulating Hormone; Humans; | 1989 |
Estrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Ethinyl Estradiol; Feedback; Female; Foll | 1989 |
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.
Topics: Dopamine Antagonists; Drug Interactions; Endorphins; Female; Humans; Luteinizing Hormone; Menopause; | 1989 |
Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.
Topics: Adult; Female; Humans; Luteinizing Hormone; Menopause; Middle Aged; Naloxone; Perfusion; Receptors, | 1988 |
Clinical and hormonal effects of long-term veralipride treatment in post-menopausal women.
Topics: Aged; Drug Administration Schedule; Female; Follow-Up Studies; Hormones; Humans; Menopause; Middle A | 1988 |
[Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
Topics: Adult; Climacteric; Female; Flushing; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans | 1985 |
[Veralipride in the treatment of hot flushes in the menopause].
Topics: Adult; Drug Evaluation; Female; Flushing; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; | 1985 |
[Agreal: its acceptibility. Review of the literature].
Topics: Adult; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Luteinizing Hormone; Menopause; M | 1985 |
[Agreal: clinical experience. Review of the literature].
Topics: Adult; Drug Evaluation; Female; Flushing; Headache; Humans; Menopause; Middle Aged; Psychophysiologi | 1985 |
[The role of Agreal in the treatment of the menopause].
Topics: Adult; Climacteric; Drug Evaluation; Estrogens; Female; Flushing; Humans; Menopause; Middle Aged; Ps | 1985 |
[Efficacy and clinical and biological tolerance of long-term veralipride administration. Apropos of 74 case reports].
Topics: Adult; Blood Chemical Analysis; Blood Pressure; Body Weight; Drug Evaluation; Female; Humans; Menopa | 1985 |
[Sulpiride and menopause].
Topics: Adult; Ergotamine; Female; Humans; Menopause; Middle Aged; Sulpiride | 1974 |